Mitochondrial protection by simvastatin against angiotensin II‐mediated heart failure-Reference-Cited by-同舟云学术

Mitochondrial protection by simvastatin against angiotensin II‐mediated heart failure

Published:2019-08-24 Issue:19 Volume:176 Page:3791-3804
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Hsieh Chong‐Chao¹²,Li Chia‐Yang³⁴^ORCID,Hsu Chih‐Hsin⁵,Chen Hsiu‐Lin⁶,Chen Yung‐Hsiang⁷⁸,Liu Yu‐Peng¹,Liu Yu‐Ru⁶,Kuo Hsuan‐Fu³⁹,Liu Po‐Len⁶¹⁰^ORCID

Affiliation:

1. Graduate Institute of Clinical Medicine, College of MedicineKaohsiung Medical University Kaohsiung Taiwan

2. Division of Cardiovascular Surgery, Department of SurgeryKaohsiung Medical University Hospital Kaohsiung Taiwan

3. Graduate Institute of Medicine, College of MedicineKaohsiung Medical University Kaohsiung Taiwan

4. Center for Infectious Disease and Cancer ResearchKaohsiung Medical University Kaohsiung Taiwan

5. Department of Internal MedicineCheng Kung University Hospital Tainan Taiwan

6. Department of Respiratory Therapy, College of MedicineKaohsiung Medical University Kaohsiung Taiwan

7. Graduate Institute of Integrated Medicine, College of Chinese MedicineChina Medical University Taichung Taiwan

8. Department of Psychology, College of Medical and Health ScienceAsia University Taichung Taiwan

9. Department of Internal Medicine, Kaohsiung Municipal Ta‐Tung HospitalKaohsiung Medical University Kaohsiung Taiwan

10. Regenerative Medicine and Cell Therapy Research CenterKaohsiung Medical University Kaohsiung Taiwan

Funder

Kaohsiung Medical University Chung-Ho Memorial Hospital

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14781

Reference55 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors

2. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

3. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview

4. Simvastatin prevents isoproterenol‐induced cardiac hypertrophy through modulation of the JAK/STAT pathway;Al‐Rasheed N. M.;Drug Design, Development and Therapy,2015

5. A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAS RECEPTOR BLOCKADE IMPAIRS EXERCISE-INDUCED CARDIAC HYPERTROPHY;Peptides;2024-09

2. Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy;World Journal of Diabetes;2024-06-15

3. Traditional Chinese medicine and mitophagy: A novel approach for cardiovascular disease management;Phytomedicine;2024-06

4. Simvastatin, Its Antimicrobial Activity and Its Prevention of Alzheimer’s Disease;Microorganisms;2024-06-01

5. 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis;Signal Transduction and Targeted Therapy;2024-05-15